It induces the proliferation of CD8 + T cells rather than Treg cells and effectively stimulates NK cells and T cells to exert their anti‐tumor activity.36 IL‐21 is also a promising cytokine with clinical application potential. The gene discussed is CD8A; the disease is neoplasm.